פריוויג'ן

País: Israel

Idioma: hebreo

Fuente: Ministry of Health

Ingredientes activos:

IMMUNOGLOBULINS, NORMAL HUMAN

Disponible desde:

CSL BEHRING LTD., ISRAEL

Código ATC:

J06BA02

formulario farmacéutico:

תמיסה לאינפוזיה

Composición:

IMMUNOGLOBULINS, NORMAL HUMAN 100 G/L

Vía de administración:

תוך-ורידי

tipo de receta:

מרשם נדרש

Fabricado por:

CSL BEHRING AG, SWITZERLAND

Grupo terapéutico:

IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM.

Área terapéutica:

IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM.

indicaciones terapéuticas:

1. Replacement therapy in- Primary immunodeficiency syndromes such as:- Congenital agammaglobulinaemia and hypogammaglobulinaemia- Common variable immunodeficiency- Severe combined immunodeficiency- Wiskott-Aldrich syndrome- Myeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections-Children with congenital AIDS and recurrent infections2. Immunomodulation- Immune thrombocytopenic purpura (ITP) in children or adults at high risk of bleeding or prior to surgical interventions to correct the platelet count-Guillain-Barr? syndrome- Kawasaki disease3. Allogeneic bone marrow transplantation

Fecha de autorización:

2016-06-30